Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review

被引:7
作者
Lattard, Claire [1 ]
Baudouin, Amandine [1 ]
Larbre, Virginie [1 ,2 ]
Herledan, Chloe [1 ,2 ]
Cerutti, Ariane [1 ]
Cerfon, Marie-Anne [1 ]
Kimbidima, Reine [1 ]
Caffin, Anne-Gaelle [1 ]
Vantard, Nicolas [1 ]
Schwiertz, Verane [1 ]
Ranchon, Florence [1 ,2 ]
Rioufol, Catherine [1 ,2 ]
机构
[1] Hosp Civils Lyon, Unite Pharm Clin Oncol, Groupement Hospitalier Sud, Pierre Benite, France
[2] Univ Lyon 1, EA 3738, CICLY Ctr Innovat Cancerol Lyon, F-69921 Lyon, Oullins, France
关键词
Cancer; Clinical pharmacy; Injectable anticancer drugs; Clinical pharmacist; POTENTIAL-DRUG INTERACTIONS; HERBAL MEDICINE USE; PHARMACEUTICAL CARE; ADVERSE EVENTS; CHEMOTHERAPY; SERVICES; INTERVENTIONS; MANAGEMENT; OUTCOMES; PROGRAM;
D O I
10.1007/s00432-023-04630-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeClinical pharmacy can reduce drug-related iatrogenesis by improving the management of adverse effects of drugs, limiting drug-drug interactions, and improving patient adherence. Given the vulnerability of cancer patients and the toxicity of injectable anticancer drugs, clinical pharmacy service (CPS) could provide a significant clinical benefit in cancer care. This review aims to synthesize existing evidence on clinical pharmacy's impact on patients treated with intravenous anticancer drugs.MethodsA comprehensive search was performed in the PubMed/Medline database from January 2000 to December 2021, associating the keywords: clinical pharmacy, pharmaceutical care, pharmacist, oncology, and chemotherapy. To be eligible for inclusion, studies have to report clinical pharmaceutical services for patients treated with intravenous chemotherapy with a clinical and/or economic impact.ResultsForty-one studies met the selection criteria. Various CPS were reported: medication reconciliation, medication review, and pharmaceutical interview with patient. There was a lack of randomized study (n = 3; 7.3%). In one randomized controlled trial, pharmaceutical intervention significantly improved quality of life of patients receiving pharmaceutical care during injectable anticancer drugs courses. Economical results appear to show positive impact of clinical pharmacy with cost savings reported from 3112.87$ to 249 844euro. Although most studies were non-comparative, they highlighted that clinical pharmacy tend to limit chemotherapy side effects and drug-related problems, improve quality of life and satisfaction of patients and healthcare professional, and a positive economic impact.ConclusionClinical pharmacy can reduce adverse drug events in cancer patients. More robust and economic evaluations are still required to support its development in everyday practice.
引用
收藏
页码:7905 / 7924
页数:20
相关论文
共 50 条
[41]   Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy [J].
Kim, DK ;
Lee, SW ;
Yoo, CG ;
Kim, YW ;
Han, SK ;
Shim, YS ;
Yim, JJ .
CHEST, 2005, 128 (04) :2218-2222
[42]   The impact of the clinical pharmacist-led interventions in China: A systematic review and Meta-Analysis [J].
Qin, Si-bei ;
Zhang, Xin-yi ;
Fu, Yu ;
Nie, Xiao-yan ;
Liu, Jian ;
Shi, Lu-wen ;
Cui, Yi-min .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) :366-377
[43]   Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review [J].
Ho, Siew Ching ;
Chong, Huey Yi ;
Chaiyakunapruk, Nathorn ;
Tangiisuran, Balamurugan ;
Jacob, Sabrina Anne .
JOURNAL OF AFFECTIVE DISORDERS, 2016, 193 :1-10
[44]   Flavonoids as anticancer therapies: A systematic review of clinical trials [J].
Bisol, Angela ;
de Campos, Paloma Santos ;
Lamers, Marcelo Lazzaron .
PHYTOTHERAPY RESEARCH, 2020, 34 (03) :568-582
[45]   Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review [J].
Najafi, Masoumeh ;
Jahanbakhshi, Amin ;
Ghersi, Sebastiano Finocchi ;
Giaccherini, Lucia ;
Botti, Andrea ;
Cavallieri, Francesco ;
Rossi, Jessica ;
Iori, Federico ;
Iotti, Cinzia ;
Ciammella, Patrizia ;
Nabiuni, Mohsen ;
Gomar, Marzieh ;
Rezaie, Omid ;
Cozzi, Salvatore .
BRAIN SCIENCES, 2023, 13 (02)
[46]   Patient reported outcomes in the daily practice in clinical oncology: A systematic review [J].
Lutz, Andreas Timoteo ;
Griza, Aline ;
Machado, Graziella Moraes ;
Loose, Uilian ;
Dahmer, Alessandra ;
Herbert, Juliana Silva .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 173
[47]   Cancer stem cell impact on clinical oncology [J].
Toledo-Guzman, Mariel E. ;
Bigoni-Ordonez, Gabriele D. ;
Ibanez Hernandez, Miguel ;
Ortiz-Sanchez, Elizabeth .
WORLD JOURNAL OF STEM CELLS, 2018, 10 (12) :183-195
[48]   Cancer stem cell impact on clinical oncology [J].
Mariel E Toledo-Guzmán ;
Gabriele D Bigoni-Ordó?ez ;
Miguel Ibá?ez Hernández ;
Elizabeth Ortiz-Sánchez .
World Journal of Stem Cells, 2018, 10 (12) :183-195
[49]   Impact of pharmacist services on economic, clinical, and humanistic outcome (ECHO) of South Asian patients: a systematic review [J].
Shrestha, Sunil ;
Shrestha, Rajeev ;
Ahmed, Ali ;
Sapkota, Binaya ;
Khatiwada, Asmita Priyadarshini ;
Christopher, Christina Malini ;
Thapa, Parbati ;
Kc, Bhuvan ;
Blebil, Ali Qais ;
Khanal, Saval ;
Paudyal, Vibhu .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
[50]   A systematic review of noninferiority margins in oncology clinical trials [J].
Hashim, Mahmoud ;
Vincken, Talitha ;
Kroi, Florint ;
Gebregergish, Samron ;
Spencer, Mike ;
Wang, Jianping ;
Kampfenkel, Tobias ;
Lam, Annette ;
He, Jianming .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) :443-455